Abstract
Extent of enhancing tumour resection is correlated with progression free survival following glioma surgery. Historically, a contrast enhanced MRI has been recommended within 72 hours following surgery to evaluate for residual disease. This theoretical window was established amidst conflicting evidence to avoid reactive enhancement. Recent studies with better designs and better imaging quality have sought to challenge this window with a more pragmatic method of evaluating residual disease.
| Original language | English (UK) |
|---|---|
| Pages (from-to) | 1224-1225 |
| Number of pages | 2 |
| Journal | JPMA. The Journal of the Pakistan Medical Association |
| Volume | 69 |
| Issue number | 8 |
| Publication status | Published - 1 Aug 2019 |
Keywords
- Neuroimaging, Early postoperative enhancement, Glioblastoma, Postoperative MRI